Image Quality Evaluation in Clinical Research: A Case Study on Brain and Cardiac MRI Images in Multi-Center Clinical Trials

被引:8
|
作者
Osadebey, Michael [1 ]
Pedersen, Marius [2 ]
Arnold, Douglas [3 ]
Wendel-Mitoraj, Katrina [4 ]
机构
[1] NeuroRx Res Inc, Montreal, PQ H2X 3P9, Canada
[2] Norwegian Univ Sci & Technol, Dept Comp Sci, N-2815 Gjovik, Norway
[3] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B2, Canada
[4] BrainCare Oy, Tampere 33520, Finland
基金
美国国家卫生研究院;
关键词
Magnetic resonance imaging (MRI); brain MRI; cardiac MRI; image quality; labeling problem; central limit theorem; normal distribution; lightness contrast and texture contrast; INTERFERON BETA-1A; MOTION; DIAGNOSIS; SAFETY; SEGMENTATION; ACQUISITION; LIMITATIONS; EFFICACY; ATROPHY; METRICS;
D O I
10.1109/JTEHM.2018.2855213
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Magnetic resonance imaging (MRI) system images are important components in the development of drugs because it can reveal the underlying pathology in diseases. Unfortunately, the processes of image acquisition, storage, transmission, processing, and analysis can influence image quality with the risk of compromising the reliability of MRI-based data. Therefore, it is necessary to monitor image quality throughout the different stages of the imaging workflow. This report describes a new approach to evaluate the quality of an MRI slice in multi-center clinical trials. The design philosophy assumes that an MRI slice, such as all natural images, possess statistical properties that can describe different levels of contrast degradation. A unique set of pixel configuration is assigned to each possible level of contrast-distorted MRI slice. Invocation of the central limit theorem results in two separate Gaussian distributions. The central limit theorem says that the mean and standard deviation of pixel configuration assigned to each possible level of contrast degradation will follow a normal distribution. The mean of each normal distribution corresponds to the mean and standard deviation of the underlying ideal image. Quality prediction processes for a test image can be summarized into four steps. The first step extracts local contrast feature image from the test image. The second step computes the mean and standard deviation of the feature image. The third step separately standardizes each normal distribution using the mean and standard deviation computed from the feature image. This gives two separate z-scores. The fourth step predicts the lightness contrast quality score and the texture contrast quality score from cumulative distribution function of the appropriate normal distribution. The proposed method was evaluated objectively on brain and cardiac MRI volume data using four different types and levels of degradation. The four types of degradation are Rician noise, circular blur, motion blur, and intensity nonuniformity also known as bias fields. Objective evaluation was validated using a proposed variation of difference of mean opinion scores. Results from performance evaluation show that the proposed method will be suitable to monitor and standardize image quality throughout the different stages of imaging workflow in large clinical trials. MATLAB implementation of the proposed objective quality evaluation method can be downloaded from (https://github.com/ezimic/Image-Quality-Evaluation).
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Workflow of quality control in multi-center clinical trials
    Zhang, Jun
    O'Dell, Craig
    Teetor, Trevor
    Hall, Nathan
    Sammet, Steffen
    Jacko, Richard
    Koppen, Milan
    Novak, Melanie
    von Tengg-Kobligk, Hendrik
    Knopp, Michael
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [2] QUALITY OF INSTITUTIONAL PARTICIPATION IN MULTI-CENTER CLINICAL-TRIALS
    SYLVESTER, RJ
    PINEDO, HM
    DEPAUW, M
    STAQUET, MJ
    BUYSE, ME
    RENARD, J
    BONADONNA, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (15): : 852 - 855
  • [3] QUALITY-CONTROL IN MULTI-CENTER CLINICAL-TRIALS
    PINEDO, HM
    SYLVESTER, R
    PAUW, MD
    BUYSE, M
    BRAMWELL, VHC
    MOURIDSEN, HT
    WAGENER, T
    VENDRIK, CPJ
    SOMERS, R
    OOSTEROM, ATV
    BONADONNA, G
    STACQUET, M
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 368 - 368
  • [4] PET/CT remote image reviews in multi-center clinical trials
    Poon, David
    Zhang, Jun
    Teetor, Trevor
    Lacey, Russell
    Hall, Nathan
    Knopp, Michael
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [5] Evaluation and control of image quality and quantification in a multi-center PET/CT clinical trial
    Geng, Jianhua
    Zhu, Yanjia
    Geng, Caizheng
    Huang, Jia
    Liu, Juzhen
    Wu, Ning
    Xin, Jun
    Xu, Hao
    Yu, Lijuan
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [6] Evaluation of SVG based ophthalmic image annotation in Internet based multi-center clinical trials
    Jain, P
    Chalam, KV
    Gupta, S
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U1255 - U1255
  • [7] Improved quality monitoring of multi-center acupuncture clinical trials in China
    Ling Zhao
    Fan-rong Liang
    Ying Li
    Fu-wen Zhang
    Hui Zheng
    Xi Wu
    [J]. Trials, 10
  • [8] Improved quality monitoring of multi-center acupuncture clinical trials in China
    Zhao, Ling
    Liang, Fan-rong
    Li, Ying
    Zhang, Fu-wen
    Zheng, Hui
    Wu, Xi
    [J]. TRIALS, 2009, 10
  • [9] Methodology for developing a multi-center clinical research study
    Thomas, SS
    Buckon, CE
    Russman, BS
    Ackman, JD
    [J]. PEDIATRIC GAIT: A NEW MILLENNIUM IN CLINICAL CARE AND MOTION ANALYSIS TECHNOLOGY, 2000, : 8 - 15
  • [10] ORGANIZATION OF MULTI-CENTER CLINICAL-TRIALS
    MEINERT, CL
    [J]. CONTROLLED CLINICAL TRIALS, 1981, 1 (04): : 305 - 312